Stabilization of activation induced cytidine deaminase by bortezomib does not confer increased drug target mutation frequency

[1]  M. Svoboda,et al.  Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer , 2012, Cancer Immunology, Immunotherapy.

[2]  Q. Dou,et al.  Advances in the understanding of mechanisms and therapeutic use of bortezomib. , 2011, Discovery medicine.

[3]  Jason C. Young,et al.  Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90 , 2010, The Journal of experimental medicine.

[4]  M. Lieber,et al.  The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.

[5]  Alberto Martin,et al.  AID constrains germinal center size by rendering B cells susceptible to apoptosis. , 2009, Blood.

[6]  F. Alt,et al.  AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development , 2008, The Journal of experimental medicine.

[7]  Jianmin Yang,et al.  Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line , 2008, Journal of Pharmacology and Experimental Therapeutics.

[8]  J. Weill,et al.  Proteasomal degradation restricts the nuclear lifespan of AID , 2008 .

[9]  J. Cohen,et al.  Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells , 2007, Journal of Virology.

[10]  L. Pasqualucci,et al.  Expression of the AID protein in normal and neoplastic B cells. , 2004, Blood.

[11]  Alberto Martin,et al.  Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas , 2002, Nature.

[12]  T. Honjo,et al.  Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.

[13]  R. Smith,et al.  Burkitt's lymphoma. , 1986, International journal of pediatric otorhinolaryngology.

[14]  L. Pasqualucci,et al.  AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.

[15]  T. Honjo,et al.  Role of AID in tumorigenesis. , 2007, Advances in immunology.